The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid.
The PBM also announced that it will make the pharmacy experience simpler for consumers with chronic conditions by eliminating ...
UNH and EPN join forces to enhance pharmacy reimbursement, ensuring fair payments and better stability for independent pharmacies.
President Donald Trump’s firing this week of two Democratic members of the Federal Trade Commission calls into question how ...
Optum Rx is shifting its payment models to better meet the needs of pharmacies and consumers, the pharmacy benefit manager ...
Optum Rx's new cost-based program uses an internal algorithm that leverages multiple available industry data sources, such as ...
UnitedHealth started making these changes over the past year, and the company aims to apply them to all prescriptions by 2028 ...
The PBM plans to stop requiring coverage authorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and ...
Optum Rx announced on Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. | Optum ...
The massive pharmacy benefit manager plans to stop requiring coverage authorizations for roughly 80 drugs used to treat ...
Optum Rx has eliminated prior authorization for almost 70 drugs for chronic diseases, about 10% of its overall pharmacy prior ...
Initiative will eliminate up to 25% of all reauthorizations, or 10% of overall prior authorizations, PBM says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results